Your browser doesn't support javascript.
loading
Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study.
Blanco-Ruiz, Marina; Amaya-Pascasio, Laura; de Torres Chacón, Reyes; Álvarez Soria, María Josefa; Arjona-Padillo, Antonio; Carrillo Bailén, María Magdalena; Milán Pinilla, Rodrigo; Pérez Ortega, Irene; Sánchez Rodríguez, Belén; Andrade Zumárraga, Luis; Valverde Moyano, Roberto; Payán Ortiz, Manuel; Castillo Fernández, Alba María; Del Toro Pérez, Cristina; González Bustos, Pablo; Agüera Morales, Eduardo; Sánchez López, Purificación; Hidalgo Martín, Beatriz; Roa Chamorro, Ricardo; Fernández Pérez, Javier; Mejías Olmedo, María Victoria; Martínez-Sánchez, Patricia.
Afiliación
  • Blanco-Ruiz M; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Amaya-Pascasio L; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • de Torres Chacón R; Stroke Unit and Department of Neurology, Virgen Macarena University Hospital, Seville, Spain.
  • Álvarez Soria MJ; Stroke Unit and Department of Neurology, Jaén University Hospital, Jaén, Spain.
  • Arjona-Padillo A; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Carrillo Bailén MM; Stroke Unit and Department of Neurology, Jaén University Hospital, Jaén, Spain.
  • Milán Pinilla R; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Pérez Ortega I; Stroke Unit and Department of Neurology, Virgen de las Nieves University Hospital, Granada, Spain.
  • Sánchez Rodríguez B; Department of Pharmacy. Torrecárdenas, University Hospital, Almería, Spain.
  • Andrade Zumárraga L; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Valverde Moyano R; Stroke Unit and Department of Neurology, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Spain.
  • Payán Ortiz M; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Castillo Fernández AM; Stroke Unit and Department of Neurology, Jaén University Hospital, Jaén, Spain.
  • Del Toro Pérez C; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • González Bustos P; Stroke Unit and Department of Neurology, Virgen de las Nieves University Hospital, Granada, Spain.
  • Agüera Morales E; Stroke Unit and Department of Neurology, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Spain.
  • Sánchez López P; Department of Internal Medicine, Torrecárdenas University Hospital, Almería, Spain.
  • Hidalgo Martín B; Stroke Unit and Department of Neurology, Jaén University Hospital, Jaén, Spain.
  • Roa Chamorro R; Stroke Unit and Department of Neurology, Virgen de las Nieves University Hospital, Granada, Spain.
  • Fernández Pérez J; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Mejías Olmedo MV; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
  • Martínez-Sánchez P; Stroke Unit and Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.
Atheroscler Plus ; 45: 32-38, 2021 Nov.
Article en En | MEDLINE | ID: mdl-36643997
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies / Observational_studies Idioma: En Revista: Atheroscler Plus Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies / Observational_studies Idioma: En Revista: Atheroscler Plus Año: 2021 Tipo del documento: Article País de afiliación: España